Description

Nevilast 30 (Stavudine/Lamivudine/Nevirapine) – Prescription Antiretroviral Medicine for HIV-1 Treatment

Nevilast 30 is a prescription antiretroviral medicine formulated with Stavudine 30 mg, Lamivudine 150 mg, and Nevirapine 200 mg, a fixed-dose combination used as part of combination therapy for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection in adults and eligible adolescents. This combination contains two Nucleoside Reverse Transcriptase Inhibitors (NRTIs)—Stavudine and Lamivudine—and one Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)—Nevirapine. Together, these medicines inhibit the reverse transcriptase enzyme required for HIV replication, helping reduce the amount of virus in the body and supporting immune system function.

Nevilast 30 helps maintain viral suppression and lowers the risk of HIV-related complications when taken consistently as prescribed. It does not cure HIV infection and should always be used under the supervision of a qualified healthcare professional.

The medicine is prescribed only after careful medical evaluation, as the appropriate treatment depends on the patient’s body weight, liver and kidney function, previous treatment history, and overall health condition. Due to the safety profile of Stavudine, this combination is generally considered only when more suitable treatment options are unavailable or inappropriate.

• Key Features

1. Contains Stavudine 30 mg, Lamivudine 150 mg, and Nevirapine 200 mg
2. Prescription-only antiretroviral medication
3. Fixed-dose oral tablet for convenient administration
4. Used as part of combination therapy for HIV-1 infection
5. Helps suppress HIV viral replication
6. Supports long-term HIV disease management
7. Manufactured under quality pharmaceutical standards

How to Take Nevilast 30

For the best therapeutic effect, take Nevilast 30 exactly as directed by your healthcare provider. The medicine is generally taken twice daily, with or without food. Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless instructed by your healthcare provider.

Take the medicine at the same time each day to maintain consistent drug levels. Never skip doses or stop treatment without consulting your physician, as doing so may lead to viral resistance and reduced treatment effectiveness.

• General Dosage Reference

Medical Condition	Recommended Adult Dose
HIV-1 Infection	One tablet twice daily as prescribed
Combination Antiretroviral Therapy	Use according to the treating physician’s recommendation
Renal or Hepatic Impairment	Dose adjustment or alternative therapy may be required
Other HIV Treatment Regimens	As directed by the treating physician

The exact dosage should always be determined by your healthcare provider based on body weight, kidney function, liver function, treatment history, and current HIV treatment guidelines.

Safety Information

Before starting Nevilast 30, tell your healthcare provider if you have liver disease, kidney disease, hepatitis B or hepatitis C infection, pancreatitis, peripheral neuropathy, diabetes, severe skin reactions, or any known allergy to Stavudine, Lamivudine, Nevirapine, or any ingredients in the medicine.

Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using this medicine. Inform your physician about all prescription medicines, over-the-counter drugs, vitamins, and herbal supplements to reduce the risk of drug interactions.

Most people tolerate Nevilast 30 well when taken as prescribed. However, some individuals may experience headache, nausea, diarrhea, abdominal discomfort, fatigue, dizziness, or skin rash. Serious side effects may include liver toxicity, severe skin reactions (including Stevens-Johnson syndrome), peripheral neuropathy, pancreatitis, lactic acidosis, and hypersensitivity reactions. Seek immediate medical attention if you experience yellowing of the skin or eyes, severe abdominal pain, blistering rash, numbness or tingling in the hands or feet, difficulty breathing, or unusual muscle weakness.

Regular monitoring of liver function and overall treatment response is recommended during therapy.

Product Specifications

Specification	Information
Brand	Nevilast 30
Generic Name	Stavudine / Lamivudine / Nevirapine
Active Ingredients	Stavudine 30 mg + Lamivudine 150 mg + Nevirapine 200 mg
Strength	30 mg / 150 mg / 200 mg
Dosage Form	Oral Tablet
Drug Class	Antiretroviral (NRTI + NRTI + NNRTI Combination)
Route of Administration	Oral
Prescription Status	Prescription Required
Storage	Store below 25°C in a cool, dry place away from moisture and direct sunlight

Frequently Asked Questions

Can Nevilast 30 be taken with food?

Yes. Nevilast 30 may generally be taken with or without food unless your healthcare provider advises otherwise.

Is Nevilast 30 a cure for HIV?

No. Nevilast 30 does not cure HIV infection. It helps suppress HIV replication and control the infection when taken consistently as prescribed.

Can Nevilast 30 be used alone?

Nevilast 30 is a fixed-dose combination containing three antiretroviral medicines and is intended to be used as a complete regimen only when prescribed by your healthcare provider. Do not combine or discontinue medicines without medical advice.

Why is regular monitoring important while taking Nevilast 30?

Regular medical monitoring helps detect liver toxicity, peripheral neuropathy, pancreatitis, and other potential adverse effects early, ensuring safe and effective treatment.

What should I do if I miss a dose?

Take the missed dose as soon as you remember if it is not close to your next scheduled dose. Do not take two doses together. Consult your healthcare provider if you are unsure.